62 related articles for article (PubMed ID: 11231943)
21. Histone deacetylase inhibition impairs normal intestinal cell proliferation and promotes specific gene expression.
Roostaee A; Guezguez A; Beauséjour M; Simoneau A; Vachon PH; Levy E; Beaulieu JF
J Cell Biochem; 2015 Nov; 116(11):2695-708. PubMed ID: 26129821
[TBL] [Abstract][Full Text] [Related]
22. The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation.
Eid N; Enani S; Walton G; Corona G; Costabile A; Gibson G; Rowland I; Spencer JP
J Nutr Sci; 2014; 3():e46. PubMed ID: 26101614
[TBL] [Abstract][Full Text] [Related]
23. Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated rats.
Toden S; Lockett TJ; Topping DL; Scherer BL; Watson EJ; Southwood JG; Clarke JM
Cancer Biol Ther; 2014; 15(11):1515-23. PubMed ID: 25482948
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
[TBL] [Abstract][Full Text] [Related]
25. Low levels of GSTA1 expression are required for Caco-2 cell proliferation.
Adnan H; Quach H; MacIntosh K; Antenos M; Kirby GM
PLoS One; 2012; 7(12):e51739. PubMed ID: 23251616
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer.
Haigentz M; Kim M; Sarta C; Lin J; Keresztes RS; Culliney B; Gaba AG; Smith RV; Shapiro GI; Chirieac LR; Mariadason JM; Belbin TJ; Greally JM; Wright JJ; Haddad RI
Oral Oncol; 2012 Dec; 48(12):1281-8. PubMed ID: 22748449
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cell cycle regulators by HDACs.
Telles E; Seto E
Front Biosci (Schol Ed); 2012 Jan; 4(3):831-9. PubMed ID: 22202094
[TBL] [Abstract][Full Text] [Related]
28. Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers.
Singh BN; Zhou H; Li J; Tipton T; Wang B; Shao G; Gilbert EN; Li Q; Jiang SW
Future Oncol; 2011 Dec; 7(12):1415-28. PubMed ID: 22112317
[TBL] [Abstract][Full Text] [Related]
29. Intestinal epithelial-specific PTEN inactivation results in tumor formation.
Byun DS; Ahmed N; Nasser S; Shin J; Al-Obaidi S; Goel S; Corner GA; Wilson AJ; Flanagan DJ; Williams DS; Augenlicht LH; Vincan E; Mariadason JM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G856-64. PubMed ID: 21836055
[TBL] [Abstract][Full Text] [Related]
30. Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells.
Serpa J; Caiado F; Carvalho T; Torre C; Gonçalves LG; Casalou C; Lamosa P; Rodrigues M; Zhu Z; Lam EW; Dias S
J Biol Chem; 2010 Dec; 285(50):39211-23. PubMed ID: 20926374
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues.
Jin KL; Pak JH; Park JY; Choi WH; Lee JY; Kim JH; Nam JH
J Gynecol Oncol; 2008 Sep; 19(3):185-90. PubMed ID: 19471575
[TBL] [Abstract][Full Text] [Related]
32. HDAC4 promotes growth of colon cancer cells via repression of p21.
Wilson AJ; Byun DS; Nasser S; Murray LB; Ayyanar K; Arango D; Figueroa M; Melnick A; Kao GD; Augenlicht LH; Mariadason JM
Mol Biol Cell; 2008 Oct; 19(10):4062-75. PubMed ID: 18632985
[TBL] [Abstract][Full Text] [Related]
33. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
34. Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent.
Orchel A; Dzierzewicz Z; Parfiniewicz B; Weglarz L; Wilczok T
Dig Dis Sci; 2005 Mar; 50(3):490-8. PubMed ID: 15810631
[TBL] [Abstract][Full Text] [Related]
35. Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines.
Buda A; Qualtrough D; Jepson MA; Martines D; Paraskeva C; Pignatelli M
Gut; 2003 May; 52(5):729-34. PubMed ID: 12692060
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
37. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis.
Bossenmeyer-Pourié C; Kannan R; Ribieras S; Wendling C; Stoll I; Thim L; Tomasetto C; Rio MC
J Cell Biol; 2002 May; 157(5):761-70. PubMed ID: 12034770
[TBL] [Abstract][Full Text] [Related]
38. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A.
Hoshimoto A; Suzuki Y; Katsuno T; Nakajima H; Saito Y
Br J Pharmacol; 2002 May; 136(2):280-6. PubMed ID: 12010777
[TBL] [Abstract][Full Text] [Related]
39. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation.
Mariadason JM; Velcich A; Wilson AJ; Augenlicht LH; Gibson PR
Gastroenterology; 2001 Mar; 120(4):889-99. PubMed ID: 11231943
[TBL] [Abstract][Full Text] [Related]
40. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation.
Mariadason JM; Rickard KL; Barkla DH; Augenlicht LH; Gibson PR
J Cell Physiol; 2000 Jun; 183(3):347-54. PubMed ID: 10797309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
